Zafgen (NASDAQ: ZFGN) issued the following statement:"Zafgen recently learned of a patient death which occurred in the Company’s ongoing double-blind ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE